scPharmaceuticals Inc

NASDAQ:SCPH   3:59:53 PM EDT
4.70
+0.58 (+14.08%)
Other Pre-Announcement

scPharmaceuticals Inc Reports Third Quarter 2021 Financial Results And Provides Business Update

Published: 11/09/2021 12:47 GMT
scPharmaceuticals Inc (SCPH) - Scpharmaceuticals Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update.
Scpharmaceuticals - Modestly Revising Timing of Furoscix NDA Resubmission to Q1 2022, Reflecting Impact That Covid-19 Has Had on Third-party Partners.
Scpharmaceuticals Inc - Sees a Net Loss for 2021 to Be in Range of $29.0 Million to $31.0 Million for Fiscal Year.
Scpharmaceuticals Inc - Sees Its Cash, Equivalents, Sufficient to Fund Operations Into 2023.
Scpharmaceuticals Inc - Qtrly Loss per Share $0.24.